A dangerous intestinal infection may soon have a more targeted treatment option. Scientists have identified a natural compound that can kill the ...

Merck & Co Inc. MRK is permanently discontinuing its bacterial infection therapy Zinplava (bezlotoxumab) for commercial ...

Researchers at Monash University have identified a gene in Clostridioides difficile (C. diff) that helps the bacterium resist ...

LANXESS offers Rely+On Medero in different packaging sizes: The single-dose format in 20- or 40-gram sachets allows the product to be dosed easily and is supported by a clear dosing table. The product ...

Specialty chemicals company LANXESS is launching Rely+On Medero, a new disinfectant for the medical sector. It is highly effective against bacteria, bacterial spores—including Clostridioides difficile ...

Scientists have discovered a natural compound that targets dangerous C. difficile bacteria without wiping out the gut's beneficial microbes. Successful early tests suggest it could lead to a gentler, ...

Researchers investigated a novel kirkovirus that could be linked to colitis and small colon impactions in horses.

In the field of infection control, many paper records, manual data entry, and data scattered across multiple systems still ...

The latest launch followed Hikma's October 14, 2026 launch of Deflazacort Tablets in four strengths for patients aged 2 years ...

“We were able to show that the natural compound argyrin B is highly effective against CDI: both in laboratory experiments and ...

A multi-omics study of lyophilized fecal microbiota transplantation and bacteria-free sterile fecal filtrate in recurrent ...

Q. I developed C diff as a result of taking the antibiotic ciprofloxacin. Even after treatment, the diarrhea would come right back. I read about fecal microbiota transplants because the C diff was ...